Goldman Sachs Reiterates Neutral on Athenahealth, Raises PT to $58

Goldman reiterated its Neutral rating on Athenahealth ATHN. At the same time, the rating agency raised its price target on the company's stock from $47 to $58. On Friday, ATHN closed the day at $57.09. Its shares lost 0.44% of their value in today's pre-market trading to stand around $56.84.